S100A4 promotes endometrial cancer progress through epithelial-mesenchymal transition regulation
Authors:
- 20 April 2016
- journal article
- research article
- Published by Spandidos Publications in Oncology Reports
- Vol. 35 (6) , 3419-3426
Abstract
Spandidos Publications is a scientific publisher with a long-standing international reputation for excellent standards and high quality science publicationsKeywords
This publication has 32 references indexed in Scilit:
- Therapeutic Targeting of Tumor Growth and Angiogenesis with a Novel Anti-S100A4 Monoclonal AntibodyPLOS ONE, 2013
- Combined aberrant expression of E-cadherin and S100A4, but not β-catenin is associated with disease-free survival and overall survival in colorectal cancer patientsDiagnostic Pathology, 2013
- Integrated genomic characterization of endometrial carcinomaNature, 2013
- Tumor Metastasis: Molecular Insights and Evolving ParadigmsCell, 2011
- S100A4-induced cell motility and metastasis is restricted by the Wnt/β-catenin pathway inhibitor calcimycin in colon cancer cellsMolecular Biology of the Cell, 2011
- VEGF-A and Tenascin-C produced by S100A4 + stromal cells are important for metastatic colonizationProceedings of the National Academy of Sciences, 2011
- Sumoylation and Nuclear Translocation of S100A4 Regulate IL-1β-mediated Production of Matrix Metalloproteinase-13Journal of Biological Chemistry, 2010
- S100A4 mediates endometrial cancer invasion and is a target of TGF-β1 signalingLaboratory Investigation, 2009
- The metastatic niche: adapting the foreign soilNature Reviews Cancer, 2009
- Complex networks orchestrate epithelial–mesenchymal transitionsNature Reviews Molecular Cell Biology, 2006